Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > New Strategic Partnership
View:
Post by WarrantOfficer on Dec 20, 2023 9:04am

New Strategic Partnership

This strategic partnership is a testament to Voyageur's unwavering commitment to excellence and innovation. It grants the distributor exclusive rights within their designated territory, acknowledging their key role in securing regulatory licensing for Voyageur's suite of five barium contrast products. Given the sensitivity and competitive nature of the barium contrast market, Voyageur remains steadfast in maintaining strict confidentiality regarding client information, pricing, and sales volumes.

I have had several days to study the latest PR. There is no avenue to follow up on the new Strategic Partnership in Central America. Is this of a concern to anyone? A person can research historic PR's and read the vagueness of statements that did not develop into forward traction. I am playing the devil's advocate hand, but is anyone else going hmmm?
Comment by lscfa on Dec 20, 2023 9:20am
Seems like a pump piece to jack stock price before another financing.  How long will it take this partner to get approval to market products in Cemtral America?  How about getting some damn sales in Canada first?
Comment by Finnexas on Dec 20, 2023 10:21am
That's right it's only been 3 years since HC APPROVALS
Comment by oldtrouf on Dec 20, 2023 11:52am
That's what shell companies do.  Not one news in the past 3 years has materialized.  The only news you can believe will be the news that they are bankrupt and cannot secure financing or government assistance.  Can you image VM having such a rare and needed product yet they cannot secure any governemt grants?  The whole situation with VM is very suspect to say the least ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities